Opendata, web and dolomites

PODIUM SIGNED

PODIUM™ - A home device and cloud-based software and algorithm for diabetic foot ulcer monitoring

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PODIUM project word cloud

Explore the words cloud of the PODIUM project. It provides you a very rough idea of what is the project "PODIUM" about.

efficacy    amputation    suffering    conventional    caused    uk    trade    complication    9m    treatment    amounting    diabetics    ulcers    mainly    9bn    pressure    dramatically    dfu    10x    5bn    introduction    diagnosis    premature    convenience    healthcare    adults    market    consequence    8bn    lifetime    model    substantial    dfus    thermographs    23    qol    temperature    prevented    85    revealed    24    global    monitoring    cloud    unsuccessful    reduce    lower    cameras    mortality    456    diabetes    effectiveness          grow    serious    25    us    limb    savings       ulcer    facilitated    2025    thermetrix    diabetic    rapid    450    amputations    threatening    sales    risk    extremely    infrared    cagr    life    deaths    60m    plus    validate    competitive    podium    sensitive    percentage    2015    considerable    europeans    290    sensitivity    improvement    experiment    esters    subscription    foot    quality    reported    suffer    imaging    2024    crystalline    roi    instead    complications    small    decreasing    75    business    1m    generating    solutions    12    physicians    8m    5m    solution    sufferers    cholesteric    diagnostic    rate    liquid    detection   

Project "PODIUM" data sheet

The following table provides information about the project.

Coordinator
THERMETRIX LTD. 

Organization address
address: TY MENTER NAVIGATION PARK SUITE 12
city: ABERCYNON
postcode: CF45 4SN
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website https://podium.care/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2019-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    THERMETRIX LTD. UK (ABERCYNON) coordinator 50˙000.00

Map

 Project objective

'There are 60m adults suffering from diabetes in Europe and 3.8m in UK (5m by 2025). Diabetes has a high mortality rate caused mainly by complications (75,000 deaths p.a., of which 24,000 are premature). One life-threatening complication of diabetes is a diabetic foot ulcer (DFU). Studies revealed a 12% to 25% lifetime risk of developing DFU for diabetics, meaning over 9m Europeans (c.456,000 to 1m in UK) might suffer from DFU in their lifetime. A serious consequence of DFU is lower limb amputation; 85% of the amputations in diabetes sufferers are reported after unsuccessful DFU treatment amounting to 290,000–450,000 amputations/year in Europe, at a cost of €2–2.5bn/year.

The PODIUM™ technology is a novel, extremely reliable and highly sensitive solution for the cost-effective diagnosis and monitoring of DFUs through rapid temperature imaging and reliable analysis of thermographs. PODIUM™ will result in increased numbers of prevented DFUs through 10X higher sensitivity than any competitive solutions. A timely response from physicians, facilitated by PODIUM™ could reduce DFU-related amputations and healthcare costs. Thermetrix’s technology will provide a considerable Quality of Life (QoL) improvement for users and enable substantial savings in healthcare even if only a very small percentage would adopt PODIUM™. The global DFU and pressure ulcers market is expected to grow from US$2.8bn in 2015 to US$4.9bn by 2024 (CAGR 6.6%).

The objectives of this project are (1) experiment with the introduction of liquid crystalline cholesteric esters instead of infrared-cameras as detection method (dramatically decreasing the cost of the method); (2) validate the higher efficacy, diagnostic value, convenience and cost-effectiveness of PODIUM™ over conventional approaches; and (3) validate the business model based on 'unit costs plus cloud subscription' with the aim of generating a ROI of 23:1 based only on European sales only.

'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PODIUM" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PODIUM" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More  

LIVELMIA (2019)

Innovative assay for microRNAs analysis

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More